Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency

  • Julia-Palacios, Natalia Alexandra|||0000-0002-2560-3970
  • Kuseyri Hübschmann, Oya|||0000-0001-6576-6566
  • Olivella, Mireia|||0000-0002-6035-3399
  • Pons, Roser|||0000-0001-6749-1906
  • Horvath, Gabriella|||0000-0003-2573-2489
  • Lücke, Thomas
  • Fung, Cheuk-Wing|||0000-0002-0105-1673
  • Wong, Suet-Na
  • Cortès-Saladelafont, Elisenda|||0000-0002-8604-2230
  • Rovira-Remisa, M Mar
  • Yıldız, Yilmaz
  • Mercimek-Andrews, Saadet
  • Assmann, Birgit|||0000-0003-0458-953X
  • Stevanović, Galina
  • Manti, Filippo|||0000-0002-2012-8410
  • Brennenstuhl, Heiko
  • Jung-Klawitter, Sabine|||0000-0001-8851-672X
  • Jeltsch, Kathrin
  • Sivri, H Serap|||0000-0001-8260-9984
  • Garbade, Sven F.|||0000-0002-7420-4757
  • García-Cazorla, Àngels
  • Opladen, Thomas|||0000-0003-4349-7662
The objective of the study is to evaluate the evolving phenotype and genetic spectrum of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD) in long-term follow-up. Longitudinal clinical and biochemical data of 22 pediatric and 9 adult individuals with SSADHD from the patient registry of the International Working Group on Neurotransmitter related Disorders (iNTD) were studied with in silico analyses, pathogenicity scores and molecular modeling of ALDH5A1 variants. Leading initial symptoms, with onset in infancy, were developmental delay and hypotonia. Year of birth and specific initial symptoms influenced the diagnostic delay. Clinical phenotype of 26 individuals (median 12 years, range 1.8-33.4 years) showed a diversifying course in follow-up: 77% behavioral problems, 76% coordination problems, 73% speech disorders, 58% epileptic seizures and 40% movement disorders. After ataxia, dystonia (19%), chorea (11%) and hypokinesia (15%) were the most frequent movement disorders. Involvement of the dentate nucleus in brain imaging was observed together with movement disorders or coordination problems. Short attention span (78.6%) and distractibility (71.4%) were the most frequently behavior traits mentioned by parents while impulsiveness, problems communicating wishes or needs and compulsive behavior were addressed as strongly interfering with family life. Treatment was mainly aimed to control epileptic seizures and psychiatric symptoms. Four new pathogenic variants were identified. In silico scoring system, protein activity and pathogenicity score revealed a high correlation. A genotype/phenotype correlation was not observed, even in siblings. This study presents the diversifying characteristics of disease phenotype during the disease course, highlighting movement disorders, widens the knowledge on the genotypic spectrum of SSADHD and emphasizes a reliable application of in silico approaches.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity

  • Planas-Serra, Laura|||0000-0002-2586-0897
  • Launay, Nathalie|||0000-0002-7498-217X
  • Goicoechea, Leire|||0000-0001-5024-1396
  • Heron, Bénédicte
  • Jou, Cristina|||0000-0002-2223-7880
  • Juliá-Palacios, Natalia
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Fourcade, Stéphane|||0000-0002-8031-5007
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • De La Torre, Carolina
  • Gelot, Antoniette
  • Marsal, Maria|||0000-0001-9678-8717
  • Loza-Alvarez, Pablo|||0000-0002-3129-1213
  • García-Cazorla, Àngels
  • Fatemi, Ali
  • Ferrer, Isidro|||0000-0001-9888-8754
  • Portero-Otin, Manel
  • Area Gómez, Estela|||0000-0002-0962-1570
  • Pujol, Aurora|||0000-0002-9606-0600
Sphingolipids function as membrane constituents and signaling molecules, with crucial roles in human diseases, from neurodevelopmental disorders to cancer, best exemplified in the inborn errors of sphingolipid metabolism in lysosomes. The dihydroceramide desaturase Δ4-dihydroceramide desaturase 1 (DEGS1) acts in the last step of a sector of the sphingolipid pathway, de novo ceramide biosynthesis. Defects in DEGS1 cause the recently described hypomyelinating leukodystrophy-18 (HLD18) (OMIM #618404). Here, we reveal that DEGS1 is a mitochondria-associated endoplasmic reticulum membrane-resident (MAM-resident) enzyme, refining previous reports locating DEGS1 at the endoplasmic reticulum only. Using patient fibroblasts, multiomics, and enzymatic assays, we show that DEGS1 deficiency disrupts the main core functions of the MAM: (a) mitochondrial dynamics, with a hyperfused mitochondrial network associated with decreased activation of dynamin-related protein 1; (b) cholesterol metabolism, with impaired sterol O-acyltransferase activity and decreased cholesteryl esters; (c) phospholipid metabolism, with increased phosphatidic acid and phosphatidylserine and decreased phosphatidylethanolamine; and (d) biogenesis of lipid droplets, with increased size and numbers. Moreover, we detected increased mitochondrial superoxide species production in fibroblasts and mitochondrial respiration impairment in patient muscle biopsy tissues. Our findings shed light on the pathophysiology of HLD18 and broaden our understanding of the role of sphingolipid metabolism in MAM function.